Logo

American Heart Association

  2
  0


Final ID:

Role of Artificial Intelligence in Screening and Diagnosis of Cardiac Amyloidosis in a Diverse Patient population 10 minutes

  • Grogan, Martha  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Harmon, David  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Author Disclosures:
    Martha Grogan: DO have relevant financial relationships ; Research Funding (PI or named investigator):Alnylam:Active (exists now) ; Advisor:NovoNordisk:Active (exists now) ; Advisor:AztraZeneca:Active (exists now) ; Consultant:Janssen:Active (exists now) ; Research Funding (PI or named investigator):Janssen:Past (completed) ; Research Funding (PI or named investigator):NovoNordisk:Active (exists now) ; Research Funding (PI or named investigator):Pfizer:Past (completed) ; Research Funding (PI or named investigator):Eidos:Active (exists now) | David Harmon: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Bridging the Gaps in the Management of Cardiac Amyloidosis - Where are we in 2024?

Sunday, 11/17/2024 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts from these authors:
Discussant: OLE & HELIOS-B

Grogan Martha, Kittleson Michelle, Nair Ajith, Grodin Justin, Ambardekar Amrut

Chronotropic Incompetence in Amyloid Cardiac Disease: A Marker of Severity?

Santos Patarroyo Sebastian, Ortega Aviles Laura, Grogan Martha, Allison Thomas

You have to be authorized to contact abstract author. Please, Login
Not Available